Fertility Test Market - Global Forecast to 2023: Emergence of Combined Kits for Dual Testing of Pregnancy and Ovulation
DUBLIN, July 17, 2018 /PRNewswire/ --
The "Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global fertility test market is expected to reach USD 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%
Growth in the market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing.
This report broadly segments the market into products, mode of purchase, application, end user, and region.
Based on product, the market is segmented into ovulation predictor kits, fertility monitors, and male fertility testing products. In 2018, the ovulation predictor kits segment is expected to account for the largest share of the market. The large share can be attributed to their low cost and high efficacy, high preference for these kits, and rising median age of first-time pregnancies in women.
Based on mode of purchase, the fertility test market is divided into two segments prescription-based and non-prescription/OTC-based. In 2018, the non-prescription/OTC-based segment is expected to account for a larger share of the market. The large share can be attributed to factors such as the increasing patient preference for home- and remote monitoring, e-commerce availability, confidentiality, & accessibility of test results, and growing initiatives taken by leading market players to develop easy-to-use and accurate products.
On the basis of application, the market is segmented into female fertility testing and male fertility testing. In 2018, the female fertility testing segment is expected to account for a larger share of the fertility test market. The large share can be attributed to factors such as decreasing female fertility rates, availability of a wide range of fertility testing options, and high cost of IVF procedures.
The market, by end user, is segmented into home care settings and hospitals, fertility clinics, and others. In 2018, the home care settings segment is expected to account for the largest share of the fertility test market. The large share can be attributed to the decline of fertility rates in women and men, increasing need for continuous monitoring of health conditions, and growing preference for home and remote monitoring.
North America is expected to dominate the global market in 2018. The decline in fertility rate, rising first-time pregnancy age, and high prevalence of PCOS (polycystic ovary syndrome) among North American women are few of the major factors contributing the large share of this regional segment. Additionally, factors such as the growing use of fertility monitoring devices for contraception, rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites are increasing the adoption of fertility test in this region. The Asia Pacific region is expected to grow at the fastest CAGR as growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors; and manufacturers and suppliers of fertility testing products are shifting their focus towards the Asian market.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Fertility Test Market Overview
4.2 Regional Analysis: Market, By Product
4.3 Fertility Testing Monitors Market, By Product
4.4 Fertility Test Market, By Mode of Purchase
4.5 Fertility Test Market, By Application
4.6 Regional Analysis: Market, By End User
4.7 Market, By Country
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing First-Time Pregnancy Age
5.2.1.2 Declining Fertility Rates Across the Globe
5.2.1.3 Launch of Advanced, Easy-To-Use Fertility Monitors With High Accuracy
5.2.1.4 Increasing Awareness About Fertility Testing
5.2.2 Restraints
5.2.2.1 Lesser Precision of Ovulation Prediction Kits
5.2.2.2 Unproven Accuracy of Urine-Based Ovulation Monitors in Pcos/Pcod Patients
5.2.3 Opportunities
5.2.3.1 Emergence of Combined Kits for Dual Testing of Pregnancy and Ovulation
5.2.3.2 Emerging Nations to Offer New Growth Avenues
5.2.3.3 High Cost and Low Accuracy of Ivf Treatment
5.2.4 Challenges
5.2.4.1 High Cost of Fertility Testing Monitors
5.3 Industry Trends
5.3.1 Rising Adoption of Basal Body Temperature-Based Ovulation Monitors
5.3.2 Easy Availability of Ovulation Monitors on E-Commerce Websites
5.4 Burning Issues
5.4.1 Increasing Use of Ovulation Tracking Mobile Apps and Fertility-Tracking Websites
5.4.2 Increasing Use of Fertility Testing Devices and Apps as A Contraceptive Measure
6 Fertility Test Market, By Product
6.1 Introduction
6.2 Ovulation Predictor Kits
6.3 Fertility Monitors
6.3.1 Urine-Based Monitors
6.3.2 Saliva-Based Monitors
6.3.3 Other Fertility Monitors
6.4 Male Fertility Testing Products
7 Fertility Test Market, By Mode of Purchase
7.1 Introduction
7.2 Non-Prescription/OTC-Based
7.3 Prescription-Based
8 Fertility Test Market, By Application
8.1 Introduction
8.2 Female Fertility Testing
8.3 Male Fertility Testing
9 Fertility Test Market, By End User
9.1 Introduction
9.2 Home Care Settings
9.3 Hospitals, Fertility Clinics, & Others
10 Fertility Tests Market, By Region
11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Product Launches and Enhancements
11.3.2 Acquisition
11.3.3 Investment
12 Company Profiles
12.1 Swiss Precision Diagnostics (SPD)
12.2 Church & Dwight
12.3 Prestige Brands Holdings (A Part of Gregory Pharmaceutical Holdings)
12.4 Biozhena
12.5 Fairhaven Health
12.6 Fertility Focus
12.7 Geratherm Medical
12.8 Hilin Life Products
12.9 Taidoc
12.10 Uebe Medical
12.11 Advacare Pharma
12.12 AVA
12.13 Babystart
12.14 Valley Electronics
12.15 Sensiia
For more information about this report visit https://www.researchandmarkets.com/research/99wx6g/fertility_test?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article